Assessment of serological assays for identifying high titer convalescent plasma

Mostrar otras versiones (1)

The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of SARS-CoV-2 serological assays and non-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnsworth, Christopher W., Case, James Brett, Hock, Karl, Chen, Rita E., O’Halloran, Jane A., Presti, Rachel, Goss, Charles W., Rauseo, Adriana M., Ellebedy, Ali, Theel, Elitza S., Diamond, Michael S., Henderson, Jeffrey P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010743/
https://www.ncbi.nlm.nih.gov/pubmed/33791711
http://dx.doi.org/10.1101/2021.03.26.21254427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010743/
https://www.ncbi.nlm.nih.gov/pubmed/33791711
http://dx.doi.org/10.1101/2021.03.26.21254427

Ejemplares similares